4
Changes in Ownership
Edgewise Therapeutics, Inc. Filed Acc 0001562180-21-005459
Options or other derivatives
- Chief Financial Officer acquired 120,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Carruthers R Michael Chief Financial Officer | 2021-08-17 | Grant or award · Stock Option (Right to Buy) | +120,000 | 120,000 | D: show line 1 in the form |
Loading xslF345X03/primarydocument.xml…